Oncolab, Inc.'s AMASŪ Test is a commercially available blood test that may allow early detection of a wide range of human cancers. It detects a circulating, cancer-specific antibody, the Anti-malignin antibody, in human serum. Oncolab has been granted additional patent claims covering advances in its antibody and antigen detection techniques, as well as potential vaccine applications of the technology.
Employees with healthy weight and BMI miss less work, more productive on the job. Ceridian LifeWorks suggests how employers can help employees maintain a healthy lifestyle.
New study presented at the 54th European Organization for Caries Research (ORCA) Congress, July 2007 confirms data also presented at the International Association of Dental Research (IADR), March 2007
Theravitae, an international stem cell company says a doctor from Hawaii is believed to be one of the first patients in the world to receive not one, but two different stem cell treatments. His first treatment injected his stem cells directly into the heart muscle to treat his congestive heart failure and now he is having more stem cells injected into his coronary arteries by catheter to treat his coronary artery disease